P. Théroux

发表

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

R. Califf, E. Topol, P. Armstrong, 2002, The Lancet.

ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)

J. W. Schaeffer, R. Califf, E. Antman, 2000 .

ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations

J. W. Schaeffer, V. Fuster, R. Califf, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris.

P. Théroux, L. Lacoste, R. Lidón, 1994, The American journal of cardiology.

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Pathophysiology of Coronary Artery Disease

P. Libby, P. Théroux, P. Théroux, 2005, Circulation.

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie

J. Ornato, R. Califf, E. Antman, 2007, Journal of the American College of Cardiology.

Fibrinopeptide A and platelet factor levels in unstable angina pectoris.

P. Théroux, J. Latour, C. LEGER-GAUTHIER, 1987, Circulation.

2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Nancy M Albert, Hani Jneid, Robert M Califf, 2013, Journal of the American College of Cardiology.

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Judith S. Hochman, Eric D. Peterson, Robert M. Califf, 2011, Circulation.

2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c

Hani Jneid, Robert M Califf, Charles R Bridges, 2011, Journal of the American College of Cardiology.

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Judith S. Hochman, Eric D. Peterson, Robert M. Califf, 2011 .

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

Carl J Pepine, Joseph S Alpert, Robert M Califf, 2002, Journal of the American College of Cardiology.

Regional Myocardial Function during Acute Coronary Artery Occlusion and Its Modification by Pharmacologic Agents in the Dog

D Franklin, J Ross, J. Ross, 1974, Circulation research.

The systolic stress-volume relationship.

P. Théroux, Y. Taeymans, 1983, Circulation.

Calcium Antagonists

D. Waters, P. Théroux, Y. Taeymans, 1983, Drugs.

Clinical manifestations and pathophysiology of myocardial ischemia with special reference to coronary artery spasm and the role of slow channel calcium blockers.

D. Waters, P. Théroux, J. Latour, 1982, Progress in cardiovascular diseases.

Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention: Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

P. Teirstein, S. Steinhubl, G. Dangas, 2001, Circulation.

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

B. Lewis, M. Sabatine, E. Braunwald, 2005, JAMA.

ACCF / AHA Focused Update 2012 ACCF / AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina / Non – ST-Elevation Myocardial Infarction ( Updating the 2007 Guideline and Replacing the 2011 Focused Update )

Judith S. Hochman, Eric D. Peterson, Hani Jneid, 2012 .

ACCF/AHA Focused Update 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction

R. Califf, E. Antman, Jeffrey L. Anderson, 2011 .

ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients

Carl J Pepine, Joseph S Alpert, Robert M Califf, 2002, Circulation.

Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in NonST-Segment Elevation Acute Coronary Syndromes

S. Yusuf, L. Piegas, S. Mehta, 2007, Annals of Internal Medicine.

Circadian variation in variant angina.

D. Waters, D. Miller, P. Théroux, 1984, The American journal of cardiology.

Myocardial Ischemia and Infarction lopidogrel Inhibits Platelet-Leukocyte nteractions and Thrombin Receptor gonist Peptide-Induced Platelet Activation n Patients With an Acute Coronary Syndrome

P. Théroux, ihui Xiao, P. Théroux, 2016 .

Antiplatelet Therapy in Coronary Disease: What Agent to Use, When, and How?

P. Théroux, P. Théroux, 1998, Journal of Thrombosis and Thrombolysis.

Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction.

V. Fuster, P. Théroux, P. Théroux, 1998, Circulation.

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.

A. Parkhomenko, M. Sabatine, A. Budaj, 2016, JAMA.

Enhancing thrombolysis with adjunctive therapy

P. Théroux, P. Théroux, 2004, Journal of Thrombosis and Thrombolysis.

ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations

J. W. Schaeffer, R. Califf, E. Antman, 2000, Circulation.

Prognostic significance of newly acquired bundle branch block after aortic valve replacement.

P. Théroux, M. Talajic, M. Dubuc, 2004, The American journal of cardiology.

Antithrombotic agents in coronary artery disease.

J. Cairns, P. Théroux, T. Meade, 2001, Chest.

The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group.

J. Brophy, P. Théroux, J. Diodati, 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.

P. Théroux, J. Lespérance, R. Lidón, 1994, Circulation.

Title : Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

R. Califf, B. Lewis, R. Giugliano, 2022 .

PATHOPHYSIOLOGY AND NATURAL HISTORY

P. Théroux, J. Latour, C. LEGER-GAUTHIER, 2005 .

Detection and assessment of unstable angina using myocardial perfusion imaging: comparison between technetium-99m sestamibi SPECT and 12-lead electrocardiogram.

P. Théroux, J. Grégoire, P. Théroux, 1990, The American journal of cardiology.

Influence of fibrinolysis and percutaneous transluminal coronary angioplasty on the frequency of ventricular premature complexes.

D. Waters, P. Théroux, M. Juneau, 1989, The American journal of cardiology.

PATHOPHYSIOLOGY AND NATURAL HISTORY

D. Waters, P. Théroux, X. Bosch, 2005 .

Spontaneous regression of coronary artery obstructions: incidence in 313 consecutive repeat angiograms.

M. Bourassa, P. Théroux, J. Lespérance, 1985, Catheterization and cardiovascular diagnosis.

Is progression of coronary artery disease occurring at bouts or as a continuous process? Serial cineangiographic studies in 44 patients.

D. Waters, P. Théroux, J. Lespérance, 1984, Computers and biomedical research, an international journal.

Redefining medical treatment in the management of unstable angina.

V. Fuster, R. Califf, E. Topol, 2011, The American journal of medicine.

Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations: Main Results of the GUARDIAN Trial

H. White, B. Chaitman, J. Schroeder, 2000, Circulation.

Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.

E. Antman, J. Mega, M. Sabatine, 2005, American heart journal.

Late (> 48 hr) myocardial infarction after PTCA: Clinical and angiographic characteristics of infarction related or not to the angioplasty site

P. Théroux, J. Tanguay, J. Lespérance, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Protection of the myocardial cell during ischemia.

P. Théroux, P. Théroux, 1999, The American journal of cardiology.

Vorapaxar in the secondary prevention of atherothrombotic events.

Marc P. Bonaca, E. Braunwald, D. Morrow, 2012, The New England journal of medicine.

Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).

R. Califf, E. Topol, H. Diener, 2008, The American journal of cardiology.

Coping with new challenges in acute coronary syndromes.

P. Théroux, B. Labarthe, P. Théroux, 2006, The Canadian journal of cardiology.

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

B. Lewis, M. Sabatine, E. Braunwald, 2005, JAMA.

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.

P. Stein, J. Dalen, P. Théroux, 1995, Chest.

Intracoronary infusion of superoxide dismutase and reperfusion injury in the pig heart

F. Fernández‐Avilés, P. Théroux, D. Garcia-Dorado, 1990, Basic Research in Cardiology.

Selective Inhibition of the Contractile Apparatus: A New Approach to Modification of Infarct Size, Infarct Composition, and Infarct Geometry During Coronary Artery Occlusion and Reperfusion

F. Fernández‐Avilés, P. Théroux, D. Garcia-Dorado, 1992, Circulation.

Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.

P. Théroux, J. Grégoire, M. Juneau, 1998, Journal of the American College of Cardiology.

Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion.

P. Théroux, M. Galiñanes, D. Garcia-Dorado, 1987, Cardiovascular research.

Diltiazem and progression of myocardial ischemic damage during coronary artery occlusion and reperfusion in porcine hearts.

F. Fernández‐Avilés, P. Théroux, M. Galiñanes, 1987, Journal of the American College of Cardiology.

Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients

M. Budoff, R. Rubinshtein, F. Gaita, 2012, Heart.

Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

M. Pfisterer, P. Armstrong, C. Granger, 2010, European heart journal.

Myocardial cell protection : a challenging time for action and a challenging time for clinical research.

P. Théroux, P. Théroux, 2000, Circulation.

Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease

R. Califf, E. Topol, F. Van de Werf, 2003, Circulation.

Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.

M. Pfeffer, J. Rouleau, E. Braunwald, 1999, Journal of the American College of Cardiology.

N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.

P. Armstrong, W. Weaver, C. Granger, 2006, The Canadian journal of cardiology.

Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).

S. Snapinn, P. Théroux, T. Huynh, 2003, American heart journal.

Effects of Diltiazem on Experimental Myocardial Ischemia and on Left Ventricular Performance

M. Bourassa, P. Théroux, J. Clozel, 1983, Circulation research.

Loss of regional ventricular postextrasystolic potentiation after coronary occlusion in dogs.

J. Ross, S. Sasayama, P. Théroux, 1977, The American journal of physiology.

Favorable effects of orally administered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction.

J. Ross, R. O'rourke, M. Crawford, 1976, The American journal of cardiology.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

P. Armstrong, C. Granger, R. Kim, 2010, American heart journal.

Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?

P. Armstrong, R. Welsh, I. Bata, 2007, Canadian journal of physiology and pharmacology.

Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes.

S. Mehta, J. Eikelboom, D. Fitchett, 2011, European heart journal.

Aspirin, Warfarin, or the Combination for Secondary Prevention of Coronary Events in Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Surgery

S. Solymoss, P. Théroux, T. Huynh, 2001, Circulation.

Are qualitative features of coronary artery lesions useful in predicting progression

D. Waters, P. Théroux, G. Hudon, 1994 .

Unstable angina: pathogenesis, diagnosis, and treatment.

P. Théroux, R. Lidón, P. Théroux, 1993, Current problems in cardiology.

Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study.

J. Tardif, C. Berry, P. Théroux, 2008, Journal of the American College of Cardiology.

Improved long-term clinical outcomes in unstable angina-patients undergoing coronary angioplasty following therapy with tirofiban and heparin

S. Snapinn, P. Théroux, E. Barr, 1998 .

Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug.

P. Théroux, M. Angioï, B. Labarthe, 2005, Journal of the American College of Cardiology.

Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).

E. Antman, M. Sabatine, E. Braunwald, 2004, The American journal of cardiology.

Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry).

P. Stone, W. Rogers, H. Anderson, 1996, The American journal of cardiology.

Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris.

D. Waters, P. Théroux, Denis Roy, 1986, The American journal of cardiology.

Previously Undiagnosed Variant Angina as a Cause of Chest Pain after Coronary Artery Bypass Surgery

D. Waters, P. Théroux, J. Crittin, 1980, Circulation.

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study.

P. Théroux, M. Knudtson, A. Fung, 1996, Circulation.

Unstable angina--report from a Canadian expert roundtable.

P. Armstrong, J. Cairns, P. Théroux, 1996, The Canadian journal of cardiology.

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.

H. White, P. Théroux, S. Borzak, 2002, American heart journal.

Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery.

P. Théroux, B. Thibault, P. de Guise, 1996, Journal of the American College of Cardiology.

Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification.

G. Dagenais, D. Mark, C. Naylor, 2009, The Canadian journal of cardiology.

Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial.

B. Chaitman, P. Théroux, A. Jessel, 2001, Journal of the American College of Cardiology.

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Forc

Hani Jneid, Charles R Bridges, Theodore G Ganiats, 2012, Journal of the American College of Cardiology.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

R. Califf, B. Lewis, R. Giugliano, 2015, The New England journal of medicine.

Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.

E. Braunwald, P. Stone, W. Rogers, 1996 .

Aspirin, heparin, or both to treat acute unstable angina.

P. Théroux, J. Mccans, M. Juneau, 1988, The New England journal of medicine.

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

A. Skene, M. Sabatine, E. Braunwald, 2005, The New England journal of medicine.

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

R. Califf, E. Antman, Jeffrey L. Anderson, 2013, Circulation.

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article

J. W. Schaeffer, R. Califf, E. Antman, 2002 .

Noninvasive assessment of aortocoronary bypass graft patency using pulsed Doppler echocardiography.

P Peronneau, M. Bourassa, B. Diebold, 1979, The American journal of cardiology.

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.

R. Califf, E. Topol, M. Simoons, 1999, Circulation.

Is variant angina the coronary manifestation of a generalized vasospastic disorder?

D. Waters, D. Miller, P. Théroux, 1981, The New England journal of medicine.

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

R. Califf, E. Antman, V. Chair, 2011, Circulation.

Aspirin Versus Heparin to Prevent Myocardial Infarction During the Acute Phase of Unstable Angina

D. Waters, P. Théroux, J. Mccans, 1993, Circulation.

Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina.

D. Waters, P. Théroux, J. Szlachcic, 1981, The American journal of cardiology.

High-performance liquid chromatographic determination of diltiazem and six of its metabolites in human urine.

P. Théroux, P. Biron, Y. Taeymans, 1984, Journal of pharmaceutical sciences.

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.

Robert Lemery, M Huther, D Brill, 1992, The New England journal of medicine.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2015, The New England journal of medicine.

Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 2: ST-segment elevation myocardial infarction.

J. Brophy, J. Cox, S. Mehta, 2011, The Canadian journal of cardiology.

2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in

Hani Jneid, Robert M Califf, Charles R Bridges, 2011, Journal of the American College of Cardiology.

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.

P. Armstrong, W. Weaver, C. Granger, 2006, European heart journal.

Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial.

B. Chaitman, P. Théroux, N. Danchin, 2003, The Journal of thoracic and cardiovascular surgery.

Prognostic value of exercise testing soon after myocardial infarction.

D. Waters, P. Théroux, C. Halphen, 1979, The New England journal of medicine.

A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians.

G. Rouleau, G. Turecki, P. Théroux, 2001, American heart journal.

Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States

Marc P. Bonaca, David A. Morrow, Benjamin M. Scirica, 2015, Journal of the American Heart Association.

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.

Deepak L. Bhatt, E. Topol, H. White, 2002, European heart journal.

H. White, P. Théroux, S. Borzak, 2002 .

Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes

Deepak L. Bhatt, R. Califf, E. Topol, 2001, Circulation.

A randomized study comparing propranolol and diltiazem in the treatment of unstable angina.

D. Waters, P. Théroux, Y. Taeymans, 1985, Journal of the American College of Cardiology.

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients

R. Califf, R. Giugliano, L. Newby, 2014, European heart journal. Acute cardiovascular care.

Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction

P. Armstrong, C. Granger, K. Mahaffey, 2016, Journal of Thrombosis and Thrombolysis.

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.

V. Hasselblad, P. Armstrong, C. Granger, 2013, International journal of cardiology.

Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial

P. Armstrong, W. Weaver, C. Granger, 2003, Circulation.

Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes

M. Irwin, N. Frasure-smith, F. Lespérance, 2007, Biological Psychiatry.

Depression and 1-year prognosis in unstable angina.

N. Frasure-smith, F. Lespérance, P. Théroux, 2000, Archives of internal medicine.

J. Brophy, E. Rahme, P. Théroux, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.

D. Waters, P. Théroux, F. Pérez-Villa, 1995, Circulation.

Antithrombotic agents in coronary artery disease.

J. Cairns, J. Hirsh, P. Théroux, 1989, Chest.

Effects of Antithrombotic Agents on Mortality and Nonfatal Cardiac Events

P. Théroux, R. Lidón, P. Théroux, 1994 .

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.

J. Douketis, N. Pannu, R. Welsh, 2011, The Canadian journal of cardiology.

Low-Dose Combined Therapy with Fluvastatin and Cholestyramine in Hyperlipidemic Patients

P. Théroux, D. Sprecher, J. Abrams, 1994, Annals of Internal Medicine.

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.

E. Antman, E. Braunwald, D. Morrow, 2002, European heart journal.

Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-P

R. Giugliano, P. Théroux, T. Luong, 2009, The Canadian journal of cardiology.

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary.

J. Douketis, N. Pannu, R. Welsh, 2011, The Canadian journal of cardiology.

Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study.

B. Chaitman, R. Bolli, P. Théroux, 2003, The Journal of thoracic and cardiovascular surgery.

Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.

C. Ballantyne, E. Stein, P. Théroux, 2006, American heart journal.

Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin

M. Dubé, Q. Duan, G. Rouleau, 2006, Psychosomatic medicine.

The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes.

M. Irwin, N. Frasure-smith, F. Lespérance, 2004, The American journal of psychiatry.

Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.

L. Deckelbaum, H. White, M. Cohen, 1999, International journal of cardiology.

Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings.

D. Gagnon, P. Théroux, J. Grégoire, 1991, Journal of the American College of Cardiology.

Reactivation of unstable angina after the discontinuation of heparin.

D. Waters, P. Théroux, J. Mccans, 1992, The New England journal of medicine.

Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.

E. Antman, R. Harrington, C. Pepine, 2003, American heart journal.

Early postinfarction ischemia: clinical, angiographic, and prognostic significance.

D. Waters, P. Théroux, X. Bosch, 1987, Circulation.

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.

P Théroux, P. Théroux, Z Xiao, 1998, Circulation.

Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2016, JAMA cardiology.

Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 1: non-ST-segment elevation ACS.

James M Brophy, Robert C Welsh, J. Brophy, 2011, The Canadian journal of cardiology.

Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.

D. Waters, P. Théroux, J. Diodati, 1990, The American journal of cardiology.

Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.

P. Théroux, Zihui Xiao, P. Théroux, 2004, Journal of the American College of Cardiology.

Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes.

P. Théroux, X. Bosch, P. Théroux, 2005, American heart journal.

Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery.

D. Waters, P. Théroux, D. Roy, 1988, Journal of the American College of Cardiology.

Myocardial infarction in patients with previous coronary artery bypass surgery.

D. Waters, P. Théroux, L. Campeau, 1984, Journal of the American College of Cardiology.

Long-term prognosis of patients with variant angina.

D. Waters, D. Miller, P. Théroux, 1987, Circulation.

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

P Théroux, D. Waters, R. Havel, 1990, Circulation.

Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB).

E. Braunwald, C. Cannon, P. Stone, 1997, The American journal of cardiology.

Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) Trial

P. Armstrong, W. Weaver, C. Granger, 2003, Circulation.

Complement activity and pharmacological inhibition in cardiovascular disease.

P. Théroux, C. Martel, P. Théroux, 2006, The Canadian journal of cardiology.

Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial.

J. Burchenal, P. Armstrong, C. Granger, 2005, European heart journal.

Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).

Manesh R. Patel, P. Armstrong, W. Weaver, 2005, The American journal of cardiology.

Ventricular arrhythmias during ergonovine-induced episodes of variant angina.

D. Waters, D. Miller, P. Théroux, 1984, American heart journal.

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.

M. Sabatine, D. Morrow, J. López-Sendón, 2015, American heart journal.

Modulation of Platelet-neutrophil Interaction with Pharmacological Inhibition of Fibrinogen Binding to Platelet GPIIb/IIIa Receptor

P. Théroux, M. Frojmovic, Zihui Xiao, 1999, Thrombosis and Haemostasis.

Avoiding interpretive pitfalls when assessing arrhythmia suppression after myocardial infarction: insights from the long-term observations of the placebo-treated patients in the Cardiac Arrhythmia Pilot Study (CAPS)

J. Myles, J. Coromilas, P. Théroux, 1991, Journal of the American College of Cardiology.

Job strain and risk of acute recurrent coronary heart disease events.

G. Dagenais, C. Brisson, P. Théroux, 2007, JAMA.

Regional Myocardial Function in the Conscious Dog During Acute Coronary Occlusion and Responses to Morphine, Propranolol, Nitroglycerin, and Lidocaine

J. Ross, S. Sasayama, P. Théroux, 1976, Circulation.

Regional Myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine.

P. Théroux, J. Ross, W S Kemper, 1976 .

Plasma endothelin-1 levels in stable and unstable angina.

P. Théroux, M. Marcil, B. Solymoss, 1993, Cardiology.

Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency: Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial

S. Snapinn, P. Théroux, J. Januzzi, 2002, Circulation.

Angiographic and clinical progression in unstable angina. From clinical observations to clinical trials.

P. Théroux, P. Théroux, 1995, Circulation.

Requirements for Membrane Attack Complex Formation and Anaphylatoxins Binding to Collagen-Activated Platelets

P. Théroux, P. Maurice, A. Bonnefoy, 2011, PloS one.

Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction.

R. Welsh, P. Théroux, P. Théroux, 2003, The American journal of cardiology.

Genetic predictors of depressive symptoms in cardiac patients

M. Dubé, Q. Duan, G. Rouleau, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Coronary artery disease in young women: clinical and angiographic features and correlation with risk factors.

D. Waters, P. Théroux, C. Halphen, 1978, The American journal of cardiology.

Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000).

P. Armstrong, P. Théroux, J. Willerson, 2000, Circulation.

Thrombosis in coronary artery disease: its pathophysiology and control

P. Théroux, P. Théroux, 2002 .

Clinical and angiographic features and prognostic significance of early postinfarction angina with and without electrocardiographic signs of transient ischemia.

D. Waters, G. Sanz, P. Théroux, 1991, The American journal of medicine.

Programmed ventricular stimulation in survivors of an acute myocardial infarction.

D. Waters, M. Bourassa, P. Théroux, 1985, Circulation.

Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.

Marc P. Bonaca, Deepak L. Bhatt, A. Parkhomenko, 2017, Journal of the American College of Cardiology.

Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Overview of Randomized Clinical Trials

V. Hasselblad, R. Califf, R. Giugliano, 2011, Circulation. Cardiovascular quality and outcomes.

Demographics, treatment and outcome of acute coronary syndromes: 17 years of experience in a specialized cardiac centre.

P. Théroux, J. Tanguay, J. Grégoire, 2006, The Canadian journal of cardiology.

Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.

N. H. Nguyen, P. Théroux, J. Genest, 2000, Journal of cardiovascular pharmacology.

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.

J. Tardif, P. Théroux, J. Dupuis, 1999, Circulation.

Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction.

H. White, K. Ramanathan, P. Théroux, 1998, Journal of the American College of Cardiology.

Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and s

S. Snapinn, P. Théroux, X. Zhao, 1999, Circulation.

Clinical outcomes of bivalirudin for ischemic heart disease.

V. Hasselblad, R. Califf, E. Topol, 1999, Circulation.

Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic intervention.

C. Cannon, W. Boden, P. Théroux, 2003, American heart journal.

B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial.

M. Sabatine, E. Braunwald, D. Morrow, 2010, Journal of the American College of Cardiology.

Evaluation and risk stratification of acute coronary syndromes using a low cut-off level of cardiac troponin T, combined with CK-MB mass determination.

M. Bourassa, P. Théroux, A. Fortier, 2004, Clinical biochemistry.

Left main stenting–as a bridge to surgery–for acute type A aortic dissection and anterior myocardial infarction

R. Petitclerc, R. Cartier, P. Théroux, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Cell-to-cell interaction: a mechanism to explain wave-front progression of myocardial necrosis.

F. Fernández‐Avilés, M. Desco, P. Théroux, 1989, The American journal of physiology.

Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients.

M. Bourassa, P. Théroux, Y. Taeymans, 1984, The American journal of cardiology.

Clinical and Angiographic Factors Associated With Coronary Artery Disease Progression of Coronary Artery Disease

Yves Taeymans, D. Waters, P. Finès, 1984 .

Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month.

D. Waters, D. Miller, P. Théroux, 1982, The American journal of cardiology.

S-T segment elevation and coronary spasm in response to exercise.

B. Chaitman, D. Waters, P. Théroux, 1981, The American journal of cardiology.

Provocative Testing with Ergonovine to Evaluate the Efficacy of Treatment with Calcium Antagonists in Variant Angina

D. Waters, P. Théroux, J. Crittin, 1979, Circulation.

A pathophysiologic basis for the clinical classification and management of unstable angina.

P. Théroux, P. Théroux, 1987, Circulation.

Left main coronary artery stenosis in young patients.

D. Waters, P. Théroux, J. Crittin, 1979, Chest.

Factors influencing the long-term prognosis of treated patients with variant angina.

D. Waters, D. Miller, P. Théroux, 1983, Circulation.

Action of nifedipine in ischemic heart disease.

D. Waters, D. Miller, P. Théroux, 1983, Canadian family physician Medecin de famille canadien.

Comparative Sensitivity of Exercise, Cold Pressor and Ergonovine Testing in Provoking Attacks of Variant Angina in Patients with Active Disease

D. Waters, D. Miller, P. Théroux, 1982, Circulation.

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty.

P. Stein, J. Dalen, P. Théroux, 1992, Chest.

Regional Myocardial Function and Dimensions Early and Late after Myocardial Infarction in the Unanesthetized Dog

D Franklin, C M Bloor, J W Covell, 1977, Circulation research.

Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.

D. Waters, M. Bourassa, P. Théroux, 1980, Chest.

Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina

S. Yusuf, M. Keltai, B. Lewis, 2001 .

Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.

S. Yusuf, M. Keltai, J. Varigos, 2001, Journal of the American College of Cardiology.

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

R. Kleiger, M. Gheorghiade, M. B. Perryman, 1986, The New England journal of medicine.

Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.

S. Nattel, J. Tardif, J. Tardif, 2000, Circulation.

Unstable angina and progression of coronary atherosclerosis.

D. Waters, M. Bourassa, P. Théroux, 1983, The New England journal of medicine.

Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugs.

D. Waters, P. Théroux, J. Szlachcic, 1981, The American journal of cardiology.

Endothelial Progenitor Cells Bind and Inhibit Platelet Function and Thrombus Formation

M. Tabrizian, P. Théroux, M. Sirois, 2009, Circulation.

Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.

S. Snapinn, P. Théroux, T. Huynh, 2005, International journal of cardiology.

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

J. Ioannidis, R. Califf, E. Steyerberg, 2006, Heart.

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

P. Armstrong, C. Granger, K. Mahaffey, 2012, Journal of Thrombosis and Thrombolysis.

R. Califf, E. Antman, Jeffrey L. Anderson, 2011, Circulation.

D. DeMets, R. Califf, E. Antman, 2013, Journal of the American College of Cardiology.

Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial.

S. Snapinn, P. Théroux, J. Januzzi, 2004, The American journal of cardiology.

Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease

P. Théroux, P. Théroux, 2003 .

Classification and risk stratification of patients with acute chest pain using a low discriminatory level of cardiac troponin T

M. Bourassa, P. Théroux, A. Fortier, 2004, Clinical cardiology.

Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes

J. Tardif, P. Théroux, J. Dupuis, 1998 .

Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries.

D. Waters, P. Théroux, Y. Taeymans, 1985, The American journal of cardiology.

Prognostic significance of progression of coronary artery disease.

P Théroux, M. Bourassa, P. Théroux, 1985, The American journal of cardiology.

The Past, the Present, the Future

P. Théroux, Pierre Théroux, P. Théroux, 2011 .

E. Antman, C. Adams, E. Peterson, 2011, Circulation.

J. W. Schaeffer, R. Califf, E. Antman, 2000 .

Glycoprotein IIb/IIIa Receptor Blockade Improves Outcomes in Diabetic Patients Presenting With Unstable Angina/Non–ST-Elevation Myocardial Infarction: Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study

S. Snapinn, P. Théroux, E. Barr, 2000, Circulation.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

P. Armstrong, C. Granger, R. Kim, 2010, American heart journal.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2015, The New England journal of medicine.

R. Califf, E. Antman, Jeffrey L. Anderson, 2011, Journal of the American College of Cardiology.

R. Califf, E. Antman, Jeffrey L. Anderson, 2012, Journal of the American College of Cardiology.

The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination.

J. Tu, M. Schull, A. Denktas, 2011, JACC. Cardiovascular interventions.

Glycoprotein IIb/IIIa Receptor Blockade Improves Outcomes in Diabetic Patients Presenting With Unstable Angina/Non–ST-Elevation Myocardial Infarction Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Cl

S. Snapinn, P. Théroux, E. Barr, 2000 .

Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease.

G. FitzGerald, P. Théroux, B. Rocca, 2001, The American journal of cardiology.

Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.

P. Théroux, T. Huynh, D. Grandmont, 2001, American Journal of Cardiology.

Pathophysiology of Unstable Angina Pectoris: Clinical, Angiographic and Therapeutic Observations

D. Waters, P. Théroux, Y. Taeymans, 1988 .

Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes.

P. Théroux, D. Cox, P. Crean, 2000, Journal of the American College of Cardiology.

A heparin-controlled study of MK-383 in unstable angina

F. Werf, C. Nienaber, P. Théroux, 1994 .

Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction.

D. Waters, P. Théroux, J. Diodati, 1990, The American journal of cardiology.

Design of a multicenter, double-blind study to assess the effects of prophylactic diltiazem on early reinfarction after non-Q-wave acute myocardial infarction: diltiazem reinfarction study.

M. Gheorghiade, W. Boden, M. Crawford, 1986, The American journal of cardiology.

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

Mario J. Garcia, P. Armstrong, W. Weaver, 2006, Journal of the American College of Cardiology.

Effects of Thrombolytic Therapy Administered 6 to 24 Hours After Myocardial Infarction on the Signal‐Averaged ECG: Results of a Multicenter Randomized Trial

E. Topol, C. Naylor, P. Armstrong, 1994, Circulation.

Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.

R. Califf, E. Topol, F. Van de Werf, 2000, American heart journal.

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations main results of the guard during ischemia against necrosis (GUARDIAN) trial

B. Chaitman, P. Théroux, N. Danchin, 2001 .

Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States

Marc P. Bonaca, E. Braunwald, D. Morrow, 2015, Journal of the American Heart Association.

UNSTABLE ANGINA Fibrinopeptide A and platelet factor levels in unstable angina pectoris

P. Théroux, J. Latour, C. LEGER-GAUTHIER, 2005 .

A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.

Wanzhen Gao, James T Stewart, Krishnan Ramanathan, 2003, American heart journal.

Pathophysiology of Coronary Artery Disease

P. Libby, P. Théroux, 2005, Circulation.

Antithrombin-III plasma activity during and after prolonged use of heparin in unstable angina.

P. Théroux, R. Lidón, D. Robitaille, 1993, Thrombosis research.

Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial

Marc P. Bonaca, E. Braunwald, D. Morrow, 2017, European heart journal. Acute cardiovascular care.

Heparin resistance in acute coronary syndromes

C. Cannon, J. Hirsh, P. Théroux, 2007, Journal of Thrombosis and Thrombolysis.

Late development of left ventricular outflow tract obstruction after repair of double-outlet right ventricle.

B. Chaitman, M. Bourassa, P. Théroux, 1976, The Journal of thoracic and cardiovascular surgery.

Oral inhibitors of platelet membrane receptor glycoprotein IIb/IIIa in clinical cardiology: issues and opportunities.

P. Théroux, P. Théroux, 1998, American heart journal.

Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention

P. Teirstein, S. Steinhubl, G. Dangas, 2001 .

Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study.

J. Tardif, C. Berry, P. Théroux, 2008, Journal of the American College of Cardiology.

Antithrombotic Therapy in Patients WithSaphenous Vein andInternal Mammary Artery Bypass Grafts

P. Théroux, S. Goldman, L. Schwartz, 2015 .

PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial

Ajai Kumar Jain, P. Armstrong, F. Van de Werf, 2007 .

Epoprostenol (Prostacyclin) in Unstable Angina

E. Rapaport, P. Théroux, J. Willerson, 1988, Journal of clinical pharmacology.

Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction.

D. Waters, P. Théroux, M. Juneau, 1992, Journal of the American College of Cardiology.

Treatment Principles and Emerging Therapies in Acute Coronary Syndromes without ST-Segment Elevation

P. Théroux, 2011 .

Quantitative Angiographic Morphology of the Coronary Artery Lesions at Risk of Thrombotic Occlusion

D. Waters, P. Théroux, Y. Taeymans, 1992, Circulation.

Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease.

D. Waters, P. Théroux, G. Gosselin, 1987, Controlled clinical trials.

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years.

R. Califf, R. Giugliano, L. Newby, 2013, International journal of cardiology.

Angiographic findings after myocardial infarction in patients with previous bypass surgery: explanations for smaller infarcts in this group compared with control patients.

D. Waters, P. Théroux, P. Crean, 1985, Circulation.

Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes.

P. Théroux, P. Tornos, D. Garcia-Dorado, 1995, Circulation.

Troponin I levels in unstable angina/non-Q wave myocardial infarction patients treated with tirofiban, a glycoprotein IIb/IIIa antagonist

R. Giugliano, K. Lewandrowski, P. Théroux, 1998 .

A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial).

P. Stone, D. Waters, A. Wu, 2000, European heart journal.

Myocardial Infarction

J. Brophy, P. Théroux, L. Joseph, 2006 .

The delay to thrombolysis: an analysis of patient and hospital characteristics

J. Brophy, P. Théroux, J. Diodati, 1998 .

Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes.

R. Giugliano, K. Lewandrowski, P. Théroux, 2000, The American journal of cardiology.

Comparison of clinical variables and variables derived from a limited predischarge exercise test as predictors of early and late mortality after myocardial infarction.

D. Waters, P. Théroux, A. Bouchard, 1985, Journal of the American College of Cardiology.

Hemodynamic and therapeutic effects of intravenous dopamine.

M. Bourassa, P. Théroux, H. Mizgala, 1977, Canadian Medical Association journal.

Hemodynamic effects of calcium ion antagonists after acute myocardial infarction.

D. Waters, M. Bourassa, P. Théroux, 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

Effects of diltiazem on atrioventricular conduction and arterial blood pressure: correlation with plasma drug concentrations.

P. Théroux, J. Billette, R. Cartier, 1984, Canadian journal of physiology and pharmacology.

A new look at coronary angiograms: plaque morphology as a help to diagnosis and to evaluate outcome

D. Waters, P. Théroux, G. Hudon, 1994, The International Journal of Cardiac Imaging.

Revisiting the Canadian Cardiovascular Society grading of stable angina pectoris after a quarter of a century of use.

G. Dagenais, C. Naylor, P. Armstrong, 2002, The Canadian journal of cardiology.

CORONARY ARTERY DISEASE Original Studies Utilization of Catheterization and Revascularization Procedures in Patients With Non-ST Segment Elevation Acute Coronary Syndrome Over the Last Decade

C. Cannon, K. Mahaffey, K. Fox, 2005 .

Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy.

M. Sabatine, P. Théroux, J. Januzzi, 2003, The American journal of cardiology.

Sinus Node Dysfunction and Sudden Cardiac Death Following Treatment with Encainide

S. Nattel, P. Théroux, M. Talajic, 1989, Pacing and clinical electrophysiology : PACE.

Non-invasive pulsed Doppler study of mitral stenosis and mitral regurgitation: preliminary study.

D. Waters, M. Bourassa, B. Diebold, 1979, British heart journal.

Long-term reproducibility and significance of provokable ventricular arrhythmias after myocardial infarction.

D. Waters, M. Bourassa, P. Théroux, 1986, Journal of the American College of Cardiology.

Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction

P. Théroux, J. Diodati, J. Latour, 1991 .

Spontaneous remission is a frequent outcome of variant angina.

D. Waters, P. Théroux, A. Bouchard, 1983, Journal of the American College of Cardiology.

Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size.

F. Fernández‐Avilés, P. Théroux, D. Garcia-Dorado, 1992, The American journal of physiology.

Initial Experience With a Direct Antithrombin, Hirulog, in Unstable Angina Anticoagulant, Antithrombotic, and Clinical Effects

P. Théroux, M. Juneau, J. Maraganore, 1993, Circulation.

Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial

H. White, B. Chaitman, J. Schroeder, 2000, Current Controlled Trials in Cardiovascular Medicine.

Clinical and angiographic factors associated with progression of coronary artery disease.

D. Waters, P. Finès, P. Théroux, 1984, Journal of the American College of Cardiology.

Medical Decision Making in the Choice of a Thrombolytic Agent for Acute Myocardial Infarction

J. Brophy, P. Théroux, L. Joseph, 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

Maximizing the benefits of thrombolytic therapy for acute myocardial infarction.

D. Massel, C. Naylor, P. Armstrong, 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Antithrombotic agents in coronary artery disease.

J. Cairns, P. Théroux, G. Sutton, 1995, Chest.

Maximal versus low level exercise testing after Q and non-Q wave myocardial infarction

D. Waters, P. Théroux, M. Juneau, 1991 .

The ergonovine test--to catch a leprechaun.

D. Waters, P. Théroux, P. Théroux, 1983, International journal of cardiology.

Comparative Sensitivity ofExercise, ColdPressor andErgonovine Testing inProvoking Attacks ofVariant AnginainPatients withActive Disease

P. Théroux, J. Szlachcic, P. Théroux, 1983 .

Coronary arterial reperfusion. III. Early and late effects on regional myocardial function and dimensions in conscious dogs.

J. Ross, S. Sasayama, P. Théroux, 1976, The American journal of cardiology.

Clinical predictors of angina following myocardial infarction.

D. Waters, P. Théroux, C. Halphen, 1979, The American journal of medicine.

Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.

P. Théroux, C. Pratt, D. Slymen, 1987, The American journal of cardiology.

Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.

M. Bourassa, P. Théroux, J. Latour, 1982, The American journal of cardiology.